INSPECTR Platform Development
Low-cost, point-of-need diagnostics
Pre-clinicalActive
Key Facts
Indication
Low-cost, point-of-need diagnostics
Phase
Pre-clinical
Status
Active
Company
About Sherlock Biosciences
Sherlock Biosciences is a pioneering diagnostics company leveraging two foundational CRISPR-based and synthetic biology platforms, SHERLOCK and INSPECTR, to create a new generation of molecular tests. The company aims to democratize diagnostics by enabling rapid, low-cost, and instrument-free detection of pathogens and genetic markers at the point-of-need. While still in the development and partnership stage, its technology has significant potential for applications in infectious disease, oncology, and at-home testing. As a private company, its progress is driven by strategic collaborations, venture funding, and the pursuit of regulatory approvals for its innovative diagnostic products.
View full company profile